Clinical Trial Update: Dapagliflozin in Physical Exercise in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dapagliflozin in physical exercise for individuals with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED